Cell therapeutic approaches for the treatment of experimentally induced liver fibrosis
dc.contributor.author | Askarova, Sholpan | |
dc.contributor.author | Umbayev, B. | |
dc.contributor.author | Tsoy, A. | |
dc.contributor.author | Bulanin, D. | |
dc.contributor.author | Ongarbayeva, N. | |
dc.contributor.author | Shalakhmetova, T. | |
dc.date.accessioned | 2015-10-28T05:15:40Z | |
dc.date.available | 2015-10-28T05:15:40Z | |
dc.date.issued | 2013 | |
dc.description.abstract | The results of our study provide evidence that HT improved animal survival and liver functions by generating an ectopic hepatic mass inside the Peyer’s patches. These observations point to the conclusion that hepatocyte transplantation into lymph nodes would improve efficacy of cell –based therapy of patients with liver fibrosis and cirrhosis. | ru_RU |
dc.identifier.uri | http://nur.nu.edu.kz/handle/123456789/545 | |
dc.language.iso | en | ru_RU |
dc.publisher | Nazarbayev University | ru_RU |
dc.subject | first research week | ru_RU |
dc.subject | healthcare | ru_RU |
dc.subject | liver fibrosis | ru_RU |
dc.title | Cell therapeutic approaches for the treatment of experimentally induced liver fibrosis | ru_RU |
dc.type | Abstract | ru_RU |